APA (7th ed.) Citation

C, D., L, M., N, W., L, S., E, C., GK, P., . . . CS, R. (2023). An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease. Science translational medicine, 15(701), eade3901. https://doi.org/10.1126/scitranslmed.ade3901

Chicago Style (17th ed.) Citation

C, Dold, et al. "An Adenoviral-vectored Vaccine Confers Seroprotection Against Capsular Group B Meningococcal Disease." Science Translational Medicine 15, no. 701 (2023): eade3901. https://doi.org/10.1126/scitranslmed.ade3901.

MLA (9th ed.) Citation

C, Dold, et al. "An Adenoviral-vectored Vaccine Confers Seroprotection Against Capsular Group B Meningococcal Disease." Science Translational Medicine, vol. 15, no. 701, 2023, p. eade3901, https://doi.org/10.1126/scitranslmed.ade3901.